Table 1 Histological findings and Cdx2 expression in the rat model of esophageal carcinogenesis.
From: CDX2 hox gene product in a rat model of esophageal cancer
Histology |  | Cdx2 expression | Group A (<10 weeks, n = 22) | Group B (10–30 weeks, n = 22) | Group C (>30 weeks, n = 20) |
|---|---|---|---|---|---|
| Â | Â | Â | cases (%) | cases (%) | cases (%) |
Non-ulcerative esophagitis | - | 22/22 (100.0%) | 22/22 (100.0%) | 20/20 (100.0%) | |
Inflammatory-ulcerative lesions | + | 15/22 (68.2%) | 14/22 (63.6%) | 16/20 (80.0%) | |
Regenerative-hyperplastic lesions | + | 10/22 (45.5%) | 8/22 (36.4%) | 10/20 (50.0%) | |
Metaplastic lesions | IM | + | 2/22 (9.1%) | 9/22 (40.9%) | 12/20 (60.0%) |
| Â | MLE | Â | Â | Â | Â |
Carcinomas | Ac | + | 0/22 (0.0%) | 8/22 (36.4%) | 7/20 (35.0%) |
| Â | SCC | - | 0/22 (0.0%) | 2/22 (9.1%) | 2/20 (10.0%) |